World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

Abstract

PROPRANOLOL HYDROCHLORIDE ORALLY DISINTEGRATING FILM (ODF) FORMULATION USING SOLVENT CASTING AND ROLLING METHOD

Febriyenti*, Regina Andayani, Nurul Hasanah Assofiah, Azizah Mursal*

ABSTRACT

Propranolol hydrochloride (HCl) is a non-selective beta-blocker that is commonly used to treat hypertension, myocardial infarction, and arrhythmia. Conventional tablet preparations often make it difficult for pediatric, geriatric, or gastrointestinal patients with gastrointestinal disorders. To overcome these problems, propranolol hydrochloride was formulated into an Orally Disintegrating Film (ODF). This thin film-shaped preparation disintegrates in the oral cavity within less than a minute, eliminating the need for water. The purpose of this study is to formulate propranolol hydrochloride into ODF using the solvent casting method and rolling method. In the solvent casting method, HPMC E3 is used as the polymer, and three types of plasticizers (glycerin, propylene glycol (PG), and polyethylene glycol (PEG) 400 were employed at two concentrations. The best formula using PEG 400 (F5) produces a transparent, homogeneous, dry film in 72 hours and with a disintegration time of 46.03 ± 0.57 seconds. Content uniformity was 95.38 ± 1.95 (AV = 7.79). The rolling method was developed to speed up the drying process and increase production. The best formula R3 using 6 ml of distilled water produces a transparent, homogeneous, quick-drying film (12 hours), has a disintegration time of 36.00 ± 1.00 seconds, and content uniformity was 99.44% (AV = 13.29).

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR